BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.800
-0.160 (-8.16%)
At close: Feb 21, 2025, 4:00 PM
1.750
-0.050 (-2.78%)
After-hours: Feb 21, 2025, 7:59 PM EST
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $12.46 million as of February 21, 2025. Its market cap has increased by 68.32% in one year.
Market Cap
12.46M
Enterprise Value
-589.59K
1-Year Change
68.32%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since July 7, 2015, BioRestorative Therapies's market cap has decreased from $15.50M to $12.46M, a decrease of -19.64%. That is a compound annual growth rate of -2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 12.50M | 26.26% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 7,500.00% |
| Dec 31, 2020 | 200.00K | - |
| Dec 31, 2019 | 200.00K | -97.87% |
| Dec 31, 2018 | 9.40M | -55.02% |
| Dec 29, 2017 | 20.90M | 39.33% |
| Dec 30, 2016 | 15.00M | 12.78% |
| Dec 31, 2015 | 13.30M | -14.19% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |